Mifepristone PCD Pharma Franchise Company
Cafoli Lifecare offers 2 Mifepristone tablet formulations for its gynaecology franchise partners. Products are manufactured at WHO-GMP certified facilities and supplied on a monopoly basis to partners holding a valid Drug License.
What is Mifepristone?
Mifepristone is a synthetic steroid that acts as a progesterone receptor antagonist, blocking the action of progesterone on the endometrium and myometrium. It is a prescription-only medicine used strictly under medical supervision. Reference information is available on MedlinePlus.
Therapeutic Applications
Mifepristone is used in obstetrics and gynaecology under registered medical supervision, in indications approved by regulatory authorities in India. It is prescribed exclusively by obstetricians and gynaecologists and is subject to strict prescription and record-keeping controls.
Why Mifepristone is a High-Potential Molecule for Distributors
Because Mifepristone is a tightly regulated, prescription-controlled molecule, relatively few PCD companies carry it — which means less crowding for the partners who do. For a distributor already calling on gynaecology clinics, it complements an existing women's health portfolio, provided all licensing and compliance requirements are strictly observed.
Why Choose Cafoli Lifecare
Cafoli offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, competitive net rates and full promotional inputs, with a network of 1000+ franchise partners across India.
References
- MedlinePlus: Mifepristone
- PubChem: Mifepristone
Our formulations of Mifepristone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: